These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 155821)

  • 21. Effects on brain cholecystokinin-8-sulfate and serotonin in adult rats after neonatal reduction of catecholamines.
    Yamamoto H; Kato T
    Neurosci Res; 1988 Feb; 5(3):265-71. PubMed ID: 2451793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholamines and serotonin in rat frontal cortex after PCPA and 6-OHDA: absolute amounts and ratios.
    Reader TA
    Brain Res Bull; 1982 May; 8(5):527-34. PubMed ID: 6214300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting the activity of 5-HT-containing neurones.
    Bramwell GJ
    Brain Res; 1974 Oct; 79(3):515-9. PubMed ID: 4278895
    [No Abstract]   [Full Text] [Related]  

  • 25. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
    Versteeg DH; van Ree JM; Provoost AP; de Jong W
    Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
    [No Abstract]   [Full Text] [Related]  

  • 26. Catecholamine release by intracerebral perfusion of 6-hydroxydopamine and desipramine.
    Martin GE; Myers RD; Newberg DC
    Eur J Pharmacol; 1976 Apr; 36(2):299-311. PubMed ID: 1278225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of central catecholamine alterations on the hypothermic response to 6-hydroxydopamine in desipramine treated rats.
    Breese GR; Howard JL
    Br J Pharmacol; 1971 Nov; 43(3):671-4. PubMed ID: 5157728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tricyclic antidepessants on attack elicited by hypothalamic stimulation: relation to brain biogenic amines.
    Dubinsky B; Karpowicz JK; Goldberg ME
    J Pharmacol Exp Ther; 1973 Dec; 187(3):550-7. PubMed ID: 4272322
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 30. Attenuation by antidepressant drugs of alcohol intake in rats.
    Daoust M; Saligaut C; Chadelaud M; Chretien P; Moore N; Boismare F
    Alcohol; 1984; 1(5):379-83. PubMed ID: 6152651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of trazodone with serotonin neurons and receptors.
    Fuller RW; Snoddy HD; Cohen ML
    Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake.
    Shaskan EG; Snyder SH
    J Pharmacol Exp Ther; 1970 Nov; 175(2):404-18. PubMed ID: 5481708
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride.
    Wagner GC; Foltin RW; Seiden LS; Schuster CR
    Pharmacol Biochem Behav; 1981 Jan; 14(1):85-8. PubMed ID: 7465611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake.
    Ross SB; Ogren SO; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1976 Aug; 39(2):152-66. PubMed ID: 947293
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex.
    Shoblock JR; Maisonneuve IM; Glick SD
    Neurochem Res; 2004 Jul; 29(7):1437-42. PubMed ID: 15202777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential depletion of storage sites for noradrenalin, dopamine and serotonin by oxypertin].
    Hassler R; Bak IJ; Kim JS
    Nervenarzt; 1970 Mar; 41(3):105-18. PubMed ID: 5447883
    [No Abstract]   [Full Text] [Related]  

  • 37. Developmental characteristics of central monoamine neurons and their reciprocal relations.
    Jonsson G
    Exp Neurol; 1976 Dec; 53(3):801-14. PubMed ID: 1001399
    [No Abstract]   [Full Text] [Related]  

  • 38. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
    Marek GJ; Vosmer G; Seiden LS
    Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S; Cerletti C
    Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.